| Drug Name: | Vecuronium (50700-72-6) |
|---|---|
| PubChem ID: | 39764 |
| SMILES: | CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-] |
| InchiKey: | VEPSYABRBFXYIB-PWXDFCLTSA-M |
| Therapeutic Category: | Cholinergic Agents, Cholinergic Antagonists, Neuromuscular Agents, Neuromuscular Blocking Agents, Neuromuscular Nondepolarizing Agents, Neurotransmitter Agents, Nicotinic Antagonists, Peripheral Nervous System Agents |
| Molecular Weight (dalton) | : | 637.744 |
| LogP | : | 2.9699 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 55.84 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category